michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I mean, there's no significant news on that. I think that the sites that are more than a year old, we are very confident that they will hit the number of 100 new -- 100 procedures per site. That number is very much intact.
I think that we are beginning to see -- very early but beginning to see more than one urologist per site at a couple of our sites now. And I think as that begins to happen, again, there also, we should feel pretty confident about getting to the 100 procedure run rate. And I think the -- at the hospital, big-name sites, our original goal was to be at about 40 procedures per year. I think that's a solid number -- continues to be a solid number.
And I think some of the newer sites are more commercial sites, and we are quite excited about some of these sites. We haven't necessarily publicly announced because they're not installed yet. But I think some of those sites, we think, could be somewhere in between these big-name hospitals and the early adopters. So, they may go beyond 40 in the first year.
So, I think from a utilization perspective, you know, I feel pretty good overall.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, so value add a year ago, I want to say was right around 40 41%. This year, it drops to 30. Is it in the presentation 36 or 736 37%? So you lose a few a few bits. It grew fast. But that Windows doors and millwork closed down the average. You know where you saw the the shrinking of the mix was really in the you know, the r&r, like you'd expect, right, the r&r, the multifamily. Some of those other areas that just don't don't keep pace right now with the single family starts businesses or products.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning. I was just hoping for a little more color on the integration process. It sounds like it's been going well so far, and you mentioned like synergies are on track, but maybe you could highlight a few of these synergies and where you might have more upside than you thought previously, now that you guys have had more time to analyze the business? Then as we look forward, do you have a better sense yet of the upside potential to Bucky's margins? I'm thinking about food, grocery, or even fuel and the timing of that as you start to layer in some of your capabilities? Thanks.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I'm going to -- Tom can cover that. We've obviously spent a lot of time on that, but Tom can give you a little more detail.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So we're working very closely with our customer, as well as the Department of Defense or a potential order of 250 tanks out of Poland. Frankly, this is a powerful system for the polls to have given their geographic location and their historical experience, particularly with folks stream and west. So if we think through the FMS process and this is an FMS sale, we're looking at somewhere between maybe in the two-year period.
But just to give you a little bit of additional color we see increased demand signals coming out of Czech Republic, Romania, Denmark, Switzerland, Spain and of course, the Middle East. The world hasn't gotten any safer.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. There's just a lot of moving pieces on that, Craig. I think it's probably premature to try to pick that. Our teams are obviously working very hard with customers to close those demand and fulfill those needs. So it really is just based on technologies and packages and what those customer requirements are. Do you have a follow-on?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning. This is Leigh calling in for Larry. Thanks for taking my question. I want to go back to NOVUM IQ for a minute. Can you talk about -- you talked about filing around the end of Q1 hopefully. Can you talk about your confidence level in launching the product in second half 2021? I believe that was the previous goal. And related to that what's the premier guidance about NOVUM IQ? Then I have a follow-up.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi Catherine. So, rest of the year we don't take the third and fourth quarter will be as high as the second quarter was, right. So, we actually expect that number to normalize or stabilize maybe some slight downward pressure on expenses. So, the guidance around low single digit was for 2022. So I may not have been clear in my comments but we do expect to see some stability in expenses and a slight decrease for the remainder of the year.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I mean, look, we think one-for-one makes the most sense. That's our bread and butter business. Why? Because quality.
Once again, when you put a lot of electronics there, you have two panels that are connected, four panels that are connected. We cannot provide that kind of exceptional quality to the homeowner. It's difficult. However, there are some regions where -- and some businesses like the commercial business that don't have the same stringent requirements.
And so for those businesses, it may be economical to use a two-panel, one microinverter IQ 8D product. And we'll be looking at that hard. It's not an easy question for us to answer. We'll be looking at that hard, but we are never going to deviate from our core product being like enough.
Like when we go to IQ 9, when we go to IQ 10, we want to make that single microinverter a lot better. That is the core for us. We are going to be making that a lot better. But in markets like Australia, for example, where our market share, we want to improve our market share, we may try some experiments.
We may. But they will be done methodically without deviating from our core platform.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Hey, guys. Thanks for taking the questions. Can we talk about maybe the -- you talked about the strategy to sort of regain the Aetna business here.
Can you go into a little bit more about that? Like to do so, would you be talking with a new group within Aetna and starting a new conversation? Or is it going to the behavioral health group that you are working with currently and discussing a new way to -- a new relationship with them? Maybe any kind of color around that would be helpful.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Comps, yes, absolutely. Also, probably the most recent comp is a good one to look at. Product launches over the pandemic are challenging in general as well. But the most recent launch [indecipherable] would be a good one to look at overall. But we as we said, as I said, my prepared remarks we do believe that based upon the market dynamics right now that the launch will be gradual over time but we think the market opportunities, just enormous. It's over a $3 billion market opportunity within the branded space. And we believe that the LYBALVI is going to compete very well in that market in the market and the brand and market conditions.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. We have a commercial team of about 40 people globally. That's kind of -- they're focused from system sales to clinical adoption to training, but that direct global sales team, along with distributors that we have in various geographies, like Eastern Europe, like Middle East, like our relationship with MicroPort, that kind of commercial effort is what we expect to drive the increase in revenue next year. And I think, that's a reasonable again assumption given what that team has shown.
They're capable of doing this year. The natural benefit you have with time and as you've commercialized Genesis more and more, there is increased comfort in the community about how it's performing, that is able to work well and that gives you a natural tailwind. And then, you also have the start to a replacement cycle that again, we got very little benefit of that during this past year, but a normalized level would incrementally add at least several more systems. And I think, that next year is going to look much more like a normalized year from a replacement cycle.
So I think, those are the ways we think about the commercial effort and what's driving revenue growth next year. And I'd also kind of add similar to what Adam's question was earlier is that we do have a plan for how to build the commercial team up in a much more robust way. So when we think about the commercial team that's needed to sustain a multiyear significant double-digit revenue growth, there is a plan in place for that. And I think, you'll see as we launch the catheter and then also as you have better clarity on some of our future innovations, why that staged approach to building the commercial team makes a lot of sense.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Hi there, Keith. I don't know if you're going to say this is the same type of question, but I want to know if you feel like Robert Half right now is set up for multiple years of strong, flexible staff and growth. Usually there's multiple years of strong growth when you add a new economic cycle. I definitely heard you say, I feel like supply is manageable. But my question really stems from you said, hey, we've really seen faster pickup of demand here than typical. So my question is when you see this faster demand than typical, do you feel like it might not be as long as you typically see.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So Randy, for P6 alone, the total capex is around TWD100 billion. And it's likely -- the spending is likely to spread out through over the next three years, so, starting from latter part of this year, bulk of that in 2022 and also nearly one-third in 2023. So that will be the key part of our capex over the next three years.
And for the original budget of TWD1.5 billion, the bulk of that will go to the 10,000 wafer 28-nanometer capacity per month at P5. That's already ongoing. And we are seeing the contribution earlier, maybe as early as next year
For Xiamen, we are also already reaching to the target -- closing to the target level of 25,000, wafer per month. And as you recall, it was about, 17,000, 18,000 wafer by -- about the same time last year. But through the extension, now it's close to the focus of the capacity right now. So maybe Jason, you want to add to few more?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Great. Thanks. Good morning. Can you guys just remind us of how much of the General Engineering market is driven by Automotive and demand and extent to which you are seeing any broadening of that market -- end-market that's recovering really versus just Automotive? It seems like Automotive has been a nice big driver here. Just -- is that broadening out within General Engineering?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning, Cory. Good to hear your voice. It's two good questions. We're planning right now to launch sometime after the PDUFA date in the second half. There's a lot of logistical issues that go into launch itself. We want to get through the FDA approval process and then we'll give you more precision as we do that.
Nemvaleukin, we have moved into the expansion cohort on the weekly. We're starting the expansion at once-weekly dose. We feel like we've qualified both the once-weekly and the once every three weeks dose. And we will indeed give you more update on those data as the year goes on. Possibly around ASCO, possibly around our Investor Day we haven't really decided yet, but that program is moving full steam ahead.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We have bit of a lag with Q3. We're caught up right now for Q4, paying real close attention to what's going on with the commodities as we're sitting here in this quarter, but the team's done a nice job of getting those pass through, so bit of a benefit and then as this thing stable -- stabilizes a little bit that lag will work its way out for the year.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's -- like I said, it's a low-cost region, so the labor costs are certainly different from the profile we have based in the U.S. Tax, I don't think it's going to have a tremendous amount of impact on our tax rate. It is -- it's a little bit higher than not having a holiday in Singapore, for example. So I think, as Larry talked about, we'll be toward the higher end of that tax rate range that we typically talk about 11% to 13%, but I'd say that's a relatively small factor in it.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I think historically, it often will take us something in the kind of 12- to 18-month range. We haven't made all the assessment here. That could be in that range. It could be a little bit longer. We do have an existing integration, so that's automatically going to be available to clients. So we don't have to wait us to be able to try to continue to add customers. And I think you'll see improvements more incrementally here because that solution is already in market, and we already have integration. But I think at a macro level, for us to really integrate the solution, it's probably going to fit into the type of time windows that we've had historically.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure, and so you know these contracts as you recognized, Johnson & Johnson is a five year contract. Now the first two years have been committed and then AstraZeneca is a three year contract with the first year only being committed at this point in time.
You know clearly as we are planning for production in the facilities, you know there's a point in time at which we need to obtain commitments for that capacity that's available and so with a sufficient lead time in advance of when that would otherwise be available, that's when those discussions would commence. So we will certainly keep you posted if and when we have additional information to provide you on that front.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'll let Jay talk about that.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
And I should say in terms of both accounts and assets, so that seems pretty good.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Okay, great. Yes, we're not going to go into that detail. I'd tell you we're on path. Things are pretty consistent with what we announced when we announced the merger back in February. So I'd say everything is going as planned.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'm not going to comment on that.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Okay, thanks. I had a couple of questions. I mean, I think the first one would be on may be the investment or capex outlook for 2021. So I'm guessing that 2020, kind of the sub $30 million level. I mean, I'm thinking that's really kind of close to sustaining not too much growth capex. I'm wondering if you could just give us a quick outlook on where you see capex going in the next year or so? And then more to the point, if you could maybe call out the more important growth or discretionary projects that you're going to be focusing on in 2021? Thanks.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Thank you, Dariusz.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks a lot.

    Prediction (one of UP, DOWN, SAME): UP